Navigation Links
New research tools for BRAMS via Sonomax Technologies
Date:4/13/2010

This release is available in French.

Montreal, April 13, 2010 - Sonomax Technologies Inc. has been selected by Montral's International Laboratory for Brain, Music and Sound Research (BRAMS) to provide miniaturized, real-time, in-ear, digital signal processing devices (DSP) to investigate experience-dependent brain plasticity in humans.

"Sonomax's digital earplugs allow us to change a person's sound perception, in real time, and to simulate different hearing problems, in and outside of the laboratory," says Dr. Marc Schnwiesner, a Universit de Montral psychology professor, principal investigator with BRAMS and a specialist in high-resolution brain imaging of the hearing system.

BRAMS is jointly affiliated with the Universit de Montral and McGill University's Montral Neurological Institute. Its research is supported by the Canada Foundation for Innovation and the Natural Sciences and Engineering Research Council.

Various time and frequency manipulations are performed on the signal pick-up by the microphone and transmitted to the subject's ear by the receiver, while monitoring changes in brain function and perception with neuroimaging techniques and behavioral tests.

"Sonomax's technology enables us to conduct tests in a real-world environment, because the devices are wearable, thus giving us experimental control outside of the laboratory," adds Dr. Schnwiesner.

The technology, along with Dr. Schnwiesner's research, allows the team to modify a participant's sound perception over several weeks, for instance by filtering out certain frequencies and change the directions of incoming sounds.

Although the five-year study is in the preliminary stage and its applications in future technology still premature, Dr. Schnwiesner hopes results will lead to new insights into human sound perception and brain plasticity, as well as improved signal processing methods to enhance a listener's auditory experience.

"The application of Sonomax's in-ear technology demonstrates the versatility of the platform," says Nick Laperle, President & CEO Sonomax Technologies Inc. The sale to BRAMS was valued at $125,000 for Sonomax.

"By providing our products to a world-class research institution such as BRAMS, we can only benefit from some of the results that Dr. Schnwiesner will produce in the future as we continue to develop and enhance our leading edge in-ear products," Mr. Laperle says.


'/>"/>

Contact: Nick Laperle
nlaperle@sonomax.com
514-889-7674
University of Montreal
Source:Eurekalert

Related medicine news :

1. New research identifies modifiable risk factors for heart disease
2. Nuvo Research announces early redemption of 5% convertible debentures
3. Researcher to track spread of disease, malware and power outages
4. UCSF Researchers Identify Regulator of Human Sperm Cells
5. Octapharma Accepting Applications for Research Grants Through March 31
6. Valentine Tailgate Party for the Girls with Festive Ideas from Beauty Research
7. New Research Shows Genes of Pregnant Women and Their Fetuses Can Increase the Risk of Preterm Labor
8. University of Maryland chemist receives Astellas Award for blindness prevention research
9. Developing a cyberinfrastructure for comparative effectiveness in cancer research
10. Women should be allowed to eat, drink during labor: Queens University researcher
11. Parkinsons disease research uncovers social barrier
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... CALNOC, the nation’s first and only ... their upcoming conference – Empowerment, Value and Collaboration – in Seattle, WA on October ... the Virginia Mason Health System in Seattle since 2000. In addition to his role ...
(Date:2/23/2017)... ... February 23, 2017 , ... Curemark, LLC announced today that the Blüm ... in children aged 3-8 with Autism, is now enrolling at three new sites. These ... the United States. , “There are currently no approved drugs that address the ...
(Date:2/23/2017)... ... 23, 2017 , ... Thomas Vas-Don suffered from severe injury due ... was able to successfully recover. In “ Origin & Insertion Charts for Massage Therapists ... the principals of massage, anatomy , trigger points and referral pain patterns ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... and lobby of a new healthcare contact center in Georgia, PENETRON Specialty Products ... of the nation’s largest healthcare systems recently invested $51 million to purchase and ...
(Date:2/22/2017)... ... 22, 2017 , ... Gevir, a New Zealand-based company that focuses on developing ... coming soon to Amazon.com, the world’s largest online retailer. , The company ... an effective natural treatment for Shelley’s Multiple Sclerosis, which she’d been diagnosed with at ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 23, 2017 Tillotts Pharma is ... Berlin office was opened in January ... The portfolio includes Entocort ® for the treatment ... of ulcerative colitis, and VistaPrep ® for bowel ... specialty pharmaceutical company focused on the treatment of gastrointestinal ...
(Date:2/23/2017)... MabVax Therapeutics Holdings, Inc . ... announces that it has received notice from the ... initiation a Phase I clinical trial with MVT-1075 ... ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is the Company,s novel fully ... the phase I clinical trial in patients with ...
(Date:2/23/2017)... 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) ( ... and dermatology biopharmaceutical company, today announced that it has ... as special advisers to the Company,s Board of ... board on financial and corporate strategy. Provectus ... of up to $2.5 million from Eric Wachter ...
Breaking Medicine Technology: